A series of (-)-beta-D-(2R,4R)-dioxolane-thymine-5'-O-aliphatic acid esters as well as amino acid esters were synthesized as prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine (DOT). The compounds were evaluated for anti-HIV activity against HIV-1(LAI) in human peripheral blood mononuclear (PBM) cells as well as for their cytotoxicity in PBM, CEM and Vero cells. Improved anti-HIV potency in vitro was observed for the compound 2-4 (5'-O-aliphatic acid esters) without increase in cytotoxicity in comparison to the parent drug. Chemical and enzymatic hydrolysis of the prodrugs was also studied, in which the prodrugs exhibited good chemical stability with the half-lives from 3 h to 54 h at pH 2.0 and 7.4 phosphate buffer. However, the prodrugs were relatively labile to porcine esterase with the half-lives from 12.3 to 48.0 min.
A series of (-)-beta-D-(2R,4R)-dioxolane-thymine-5'-O-aliphatic acid esters as well as n class="Chemical">amino acid esters were synthesized as prodrugs of (-)-beta-D-(2R,4R)-dioxolane-thymine (DOT). The compounds were evaluated for anti-HIV activity against HIV-1(LAI) in human peripheral blood mononuclear (PBM) cells as well as for their cytotoxicity in PBM, CEM and Vero cells. Improved anti-HIV potency in vitro was observed for the compound 2-4 (5'-O-aliphatic acid esters) without increase in cytotoxicity in comparison to the parent drug. Chemical and enzymatic hydrolysis of the prodrugs was also studied, in which the prodrugs exhibited good chemical stability with the half-lives from 3 h to 54 h at pH 2.0 and 7.4 phosphate buffer. However, the prodrugs were relatively labile to porcine esterase with the half-lives from 12.3 to 48.0 min.
Authors: Tetsuo Satoh; Palmer Taylor; William F Bosron; Sonal P Sanghani; Masakiyo Hosokawa; Bert N La Du Journal: Drug Metab Dispos Date: 2002-05 Impact factor: 3.922
Authors: Xueqin Song; Balvinder S Vig; Philip L Lorenzi; John C Drach; Leroy B Townsend; Gordon L Amidon Journal: J Med Chem Date: 2005-02-24 Impact factor: 7.446
Authors: H O Kim; S K Ahn; A J Alves; J W Beach; L S Jeong; B G Choi; P Van Roey; R F Schinazi; C K Chu Journal: J Med Chem Date: 1992-05-29 Impact factor: 7.446
Authors: R F Schinazi; J P Sommadossi; V Saalmann; D L Cannon; M Y Xie; G C Hart; G A Smith; E F Hahn Journal: Antimicrob Agents Chemother Date: 1990-06 Impact factor: 5.191
Authors: H Chen; R F Schinazi; P Rajagopalan; Z Gao; C K Chu; H M McClure; F D Boudinot Journal: AIDS Res Hum Retroviruses Date: 1999-12-10 Impact factor: 2.205
Authors: H O Kim; R F Schinazi; S Nampalli; K Shanmuganathan; D L Cannon; A J Alves; L S Jeong; J W Beach; C K Chu Journal: J Med Chem Date: 1993-01-08 Impact factor: 7.446
Authors: Stephan Menne; Ghazia Asif; Jannan Narayanasamy; Scott D Butler; Andrea L George; Selwyn J Hurwitz; Raymond F Schinazi; Chung K Chu; Paul J Cote; John L Gerin; Bud C Tennant Journal: Antimicrob Agents Chemother Date: 2007-07-02 Impact factor: 5.191